Central Sleep Apnea

0
Pipeline Programs
2
Companies
3
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

2 companies ranked by most advanced pipeline stage

R
ResMedSAN DIEGO, CA
2 programs
Adaptive Servo-VentilationN/A1 trial
telemonitoringN/A1 trial
Active Trials
NCT03032029Completed847Est. Jul 2022
NCT02356367Withdrawn0Est. May 2017
P
PhilipsNetherlands - Amsterdam
1 program
DreamStation BiPAP autoSVN/A1 trial
Active Trials
NCT03421704Completed129Est. Apr 2023

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
PhilipsDreamStation BiPAP autoSV
ResMedAdaptive Servo-Ventilation
ResMedtelemonitoring

Clinical Trials (3)

Total enrollment: 976 patients across 3 trials

NCT03421704PhilipsDreamStation BiPAP autoSV

A Prospective Multicenter Registry of Patients With Sleep Disordered Breathing Treated With DreamStation BiPAP autoSV.

Start: Jan 2018Est. completion: Apr 2023129 patients
N/ACompleted
NCT03032029ResMedAdaptive Servo-Ventilation

Registry on the Treatment of Central and Complex Sleep-Disordered Breathing With Adaptive Servo-Ventilation

Start: Sep 2017Est. completion: Jul 2022847 patients
N/ACompleted
NCT02356367ResMedtelemonitoring

French Cohort Study of Chronic Heart Failure Patients With Central Sleep Apnoea Eligible for Adaptive Servo-Ventilation (PaceWave, AutoSet CS, AirCurve 10CS): Predictive Factors of Poor Compliance (FACE)

Start: May 2016Est. completion: May 20170
N/AWithdrawn

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

2 companies competing in this space